Zactigis is particularly suitable for mild to moderate acne, in both adolescents and adults. A significant proportion of people affected by acne do not receive any medical follow-up, especially after the age of 25. Zactigis targets these individuals by offering an accessible, structured, and consistent approach. However, in cases of severe or widespread inflammatory acne, medical advice remains essential.

Acne considered mild can worsen over time if left untreated. Early imbalances often lead to overproduction of sebum and chronic inflammation, increasing the risk of persistent lesions and residual marks. Waiting for the condition to deteriorate sometimes necessitates more aggressive treatments, whereas a gentle, early approach often allows for better control of its progression.

Many drying products and treatments destroy the skin's protective seborrheic layer. This aggression frequently triggers a compensatory reaction, with increased sebum production, altered skin flora, and clogged pores. In the long term, these mechanisms perpetuate the vicious cycle of acne. The Zactigis approach, on the other hand, aims to respect the skin's ecosystem, an essential condition for stable and healthy skin.

The SkinCTRL formula combines, among other things, vitamin B6, involved in hormonal regulation; zinc, essential for cell division and healing; vitamin C, which supports collagen synthesis and protects against oxidative stress; copper, involved in managing free radicals; and niacin, which helps normalize the skin. The overall effect is balanced, without unnecessary overload.

Zactigis SkinCTRL is a dietary supplement with a well-established tolerability and no known significant side effects. The products in this range are designed to support the skin's natural functions without the use of harsh or unnecessary substances. In case of specific circumstances or associated medical conditions, it is recommended to consult a healthcare professional.

Yes. Zactigis solutions can be used in conjunction with topical treatments prescribed by a doctor. SkinCTRL can also be used in combination with retinol A therapy and is part of a strategy to reduce the use of preventive antibiotics, when possible and appropriate. The goal is to offer a complementary approach that does not conflict with medical follow-up.

The first effects may appear after several weeks of regular use. A two- to three-month course of treatment is generally recommended to allow the skin to regain a lasting and stable balance.